Aim 1: Characterize factors that modify the effect of APOE 4 on cognitive decline and on AD ATN(vi) biomarkers, with an emphasis on vascular, metabolic, and ethnic influences, in concert with the new Center for Personalized Brain Health (CPBH).
This post was written by:
adrc_admin - who has written 76 posts on ADRC.